scispace - formally typeset
L

Liang Zheng

Researcher at Strathclyde Institute of Pharmacy and Biomedical Sciences

Publications -  44
Citations -  8226

Liang Zheng is an academic researcher from Strathclyde Institute of Pharmacy and Biomedical Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 25, co-authored 29 publications receiving 6625 citations. Previous affiliations of Liang Zheng include University of Strathclyde & University of Glasgow.

Papers
More filters
Journal ArticleDOI

Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells

TL;DR: It is shown that human cancer cells rapidly use exogenous serine and that serine deprivation triggered activation of the serine synthesis pathway and rapidly suppressed aerobic glycolysis, resulting in an increased flux to the tricarboxylic acid cycle.
Journal ArticleDOI

mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BP-Dependent Translational Regulation

TL;DR: It is demonstrated that mTORC1 controls mitochondrial activity and biogenesis by selectively promoting translation of nucleus-encoded mitochondria-related mRNAs via inhibition of the eukaryotic translation initiation factor 4E (eIF4E)-binding proteins (4E-BPs).
Journal ArticleDOI

p53 status determines the role of autophagy in pancreatic tumour development

TL;DR: It is shown, in a humanized genetically-modified mouse model of pancreatic ductal adenocarcinoma (PDAC), that autophagy’s role in tumour development is intrinsically connected to the status of the tumour suppressor p53, and treatment with hydroxychloroquine significantly accelerates tumour formation in mice containing oncogenic Kras but lacking p53.
Journal ArticleDOI

A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence

TL;DR: It is shown that the mitochondrial gatekeeper pyruvate dehydrogenase (PDH) is a crucial mediator of senescence induced by BRAFV600E, an oncogene commonly mutated in melanoma and other cancers, and a mechanistic relationship between OIS and a key metabolic signalling axis is revealed, which may be exploited therapeutically.